Proof-of-principle study is the first to use CRISPR technology on the “repeat genome,” as well as its first successful use in primary human muscle cells BOSTON, MA (PRWEB) NOVEMBER 04,… Read More »
Gene Interference Technology Used Against FSH Muscular Dystrophy Genetic Defect
International workshop spotlights progress in facioscapulohumeral muscular dystrophy research
Report by Charis Himeda, PhD The FSH Society’s 2015 International Research Consortium and Research Planning Meetings, held in Boston on October 5-6, 2015, brought together over 100 investigators, including leaders… Read More »
Watch DUX4 switch on in facioscapulohumeral MD muscle cells
In this amazing time-lapse video, as immature muscle cells (myoblasts) develop and fuse to form elongated myotubes, the nuclei inside the cells glow green as they express DUX4 protein, a key player… Read More »
Why seek genetic testing for Facioscapulohumeral muscular dystrophy?
Even without treatment, a diagnosis is therapeutic By Asifa Lalji (from her article in the FSH Watch Newsletter Spring/Summer 2015) When the Canadian provincial government of British Columbia decided it… Read More »
International facioscapulohumeral muscular dystrophy research conference in Boston
The FSH Society’s 2015 Facioscapulohumeral Muscular Dystrophy (FSHD) International Research Consortium and Planning Meeting will convene in Boston this year, on October 5-6. This meeting is the largest annual forum… Read More »